Innate immune recognition Flashcards

1
Q

The innate immune system recognises

A
  1. Highly conserved molecular patterns expressed by large groups of pathogens.
  2. Common biologic consequences of infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PAMPs

A

Gram positive bacteria: lipoteichoic acid, peptidoglycan, lipoproteins, DNA, flagellin

Gram negative: all the same plus lipopolysaccharide

Virus: coat protein, nucleic acid

Parasite: GPI anchor

Yeast: zymosan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gram+
Gram-

A

Thick cell wall with no outer envelope

Thin cell wall with outer envelope.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DAMPs

A

Endogenous molecules - signal tissue injury and initiate repair.

Molecules: DNA, RNA, Glucose
Particles: Amyloid-B, Silica, Nanoparticles
Others: UVB, Mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PRRs

A

Secreted and circulating receptors.

Receptors on the cell surface and cell membranes.

Receptors inside cells (cytoplasmic).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Secreted and circulating PRRs

A

Antimicrobial peptides secreted into lining fluids (from epithelia and phagocytes).

Pentraxins: proteins like CRP; react with the C-polysaccharide of pneumococci, some antimicrobial actions. Activate complement, promotes phagocytosis.

Lectins and collectins: CHO-containing proteins, bind CHO or lipids on microbe walls. Activate complement, improve phagocytosis.
MBL and Surfactant proteins A and D.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cell associated PRRs

A

Receptors present on the cell membrane or on organelles within the cytosol.

TLRs main one.

Recognise a broad range of molecular patterns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TLRs and their ligands (examples)

A

TLR1/2 -> triacyl lipopeptides
TLR2 -> peptidoglycan, hemagglutinin, inositol, mucin, zymosan, SARS-COV-19.
TLR5 -> flagellin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TLR and PAMP signalling

A

Different TLRs activate different signalling cascades (depending what pathogen they bind) and tailor the immune response accordingly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TLR signalling and DAMPs

A

TLR2,4,6 -> inflammation repair

TLR7, 9 -> autoimmunity + inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other membrane bound PRRs

A

Mannose receptor (on macrophages) - fungi.

Dectin-1 (on phagocytes) -> beta glucans in fungal walls.

Scavenger receptors (on macrophages) -> wide range of lipid related ligands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

RIG-I-like Receptors (RLRs)

A

Detect viral RNA in the cytoplasm:

Retinoic acid-inducible gene I (RGI-I)
Influenza A and Respiratory Syncytial virus.
short dsRNA, 5’ppp caps

Melanoma differentiated gene 5 (MDA-5) long ds RNA
Rhinovirus

Laboratory of genetics and physiology 2 (LGP2). dsRNA
Positive regulator for other two.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NOD-like receptors

A

Sensing cytoplasmic bacterial pathogens and DAMPs.

Regulates inflammatory and cell death responses.

Nucleotide-binding and oligomerisation domain (NOD=NACHT)

4 subfamilies - based on N-terminal effector domain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NOD1

A

Activated by meso-aminopimelic acid (Meso-DAP)-containing PGN fragments (gram-) in periplasmic space.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NOD2

A

Muramyl dipeptide (MDP)=breakdown of PG in the cell wall. ~ in all gram negative and positive bacteria.

Dynamically traffic to intracellular membranes upon detection of PG derivatives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NOD signalling

A

Activation of MAPK and NF-KB

Induction of pro-inflammatory cytokines and chemokines

Activation of antimicrobial functions

DO NOT activate IRF transcription factors (interferon regulatory factors).

17
Q

Inflammatory response to infection

A

NFkB-MAPK

IL1B - activates vascular endothelium and lymphocytes. Local tissue destruction= increased access to effector cells.
FEVER and production of IL-6.

TNF-A- Increased vascular permeability. IgG increased lymph drainage.
FEVER.

IL-6 - lymphocyte activate and increased AB production.

CXCL8 - recruits neutrophils, basophils and T cells.

IL-12 - activate NK cells induces diff of CD4 into Th1.

18
Q

Acute phase response (actions of IL-1B/IL-6/TNF-alpha)

A

Liver: acute phase proteins (C-reactive; MBL) -> activation of complement opsonisation.

Bone marrow endothelium: neutrophils -> phagocytosis.

Hypothalamus: increased body T -> decreased replication; increased AG processing, increased spec. immune response.

Fat, muscle: protein and energy mobilisation: allows for increased temp. -> decreased replication; increased AG processing, increased spec. immune response.

Dendritic cells: TNF-alpha stimulation migration to lymph nodes and maturation -> initiates adaptive response.

19
Q

What is the interferon stimulated response element made up of?

A

STAT1, STAT2, IRF9

Activates macrophages and dendritic cells.

Activate NK to kill viral cells.

Induces chemokines to recruit lymphocytes.

Induces resistance to viral replication (destruct mRNA; inhibits translation)

Increases MHC-I expression and AG presentation (CD8)

20
Q

The damage chain reaction

A

Harmful stimuli
Pathogen
Injury
Heat
Autoantigens
Tumours
Necrotic cells

High levels of DAMPs - associated with inflammatory and autoimmune disorders as well as atherosclerosis and CA.

21
Q

Cytokine storm

A

Profound increase in CK, CXCL, and INFs= severe inflammation and tissue damage.

Induced by: genetic makeup of host, persistent pathogen

Role in sepsis.

22
Q

Immunomodulation has two main strategies…

A

Agonists and antagonists.

23
Q

Agonists (enhance TLR signalling)

A

Adjuvant effect - promotes protective responses, i.e. vaccines

Immune stimulators.

Modify adaptive immune response: Th and Treg

Side effect: potentially enhance inflammation.

24
Q

Antagonists (inhibit TLR signalling)

A

Block receptor-ligand binding -> interferes with signalling.

Sepsis syndromes, inflammation, arthritis.

Side-effects: allow pathogen outgrow, mutation.

25
Q

NOD2 mutations

A

Non functions mutation: Crohn’s disease

Hyperfunctioning mutations: Blau syndrome (granulomatous inflammation of skin, eyes, joints).

26
Q

TLR7 mutation

A

Novel gain of function: SLE

27
Q

TLR4 mutation

A

Asp299Gly and Thr399Ile overexpressed in infants <12 months = hospitalised for RSV bronchiolitis.

Fail to translocate TLR4 to cell surface - reduced NFkB signalling.